Previous 10 | Next 10 |
2024-05-08 14:17:12 ET More on Royalty Pharma Royalty Pharma: Solid Operational Performance Royalty Pharma PLC (RPRX) Q4 2023 Earnings Call Transcript Royalty Pharma plc 2023 Q4 - Results - Earnings Call Presentation Teva, Medincell succeed in late-stage tria...
2024-05-08 10:13:13 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries Limited 2024 Q1 - Results - Earnings Call Presentation Teva Pharmaceutical Industries: Potential Outweighs Concerns Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportu...
2024-05-08 07:40:43 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries: Potential Outweighs Concerns Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Pos...
2024-05-04 01:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-02 16:17:14 ET More on Arrowhead Pharmaceuticals Arrowhead: RNAi Specialist Struggling To Show A Strong Hand (Rating Downgrade) Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2024 Earnings Call Transcript Arrowhead Pharmaceuticals jumps amid takeover speculation ...
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m...
2024-04-17 08:17:48 ET More on Royalty Pharma Royalty Pharma: Solid Operational Performance Royalty Pharma PLC (RPRX) Q4 2023 Earnings Call Transcript Royalty Pharma plc 2023 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Roy...
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on June 14, 2024, to shareholders of record at the clos...
2024-04-11 14:10:34 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are some pharma stocks to sell in April. Holding these companies is too risky, especially as the industry faces increasing regulatory scrutiny and pricing pressures. Several major pharmac...
2024-04-09 12:24:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today we dive deeper than the headlines to uncover overlooked stocks. In the artificial intelligence ( AI ) market of 2024, tech gi...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on September 13, 2024, to shareholders of record at the...